Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.
2.

MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.

Lee H, Kim KR, Cho NH, Hong SR, Jeong H, Kwon SY, Park KH, An HJ, Kim TH, Kim I, Yoon HK, Suh KS, Min KO, Choi HJ, Park JY, Yoo CW, Lee YS, Lee HJ, Lee WS, Park CS, Lee Y; Gynecological Pathology Study Group of the Korean Society of Pathologists.

World J Surg Oncol. 2014 Nov 8;12:334. doi: 10.1186/1477-7819-12-334.

3.

Screening for Cervical Cancer: A Review of Outcome among Infertile Women in a Tertiary Hospital in North-West Nigeria.

Nnadi D, Nwobodo E, Ekele B, Sahabi S.

Ann Med Health Sci Res. 2014 May;4(3):383-7. doi: 10.4103/2141-9248.133464.

4.

Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.

Malogajski J, Brankovic I, Verweij SP, Ambrosino E, van Agtmael MA, Brand A, Ouburg S, Morré SA.

Biomed Res Int. 2013;2013:892106. doi: 10.1155/2013/892106. Epub 2013 May 23.

5.

Regional variation in histopathology-specific incidence of invasive cervical cancer among Peruvian women.

Pierce Campbell CM, Curado MP, Harlow SD, Soliman AS.

Int J Gynaecol Obstet. 2012 Jan;116(1):47-51. doi: 10.1016/j.ijgo.2011.08.008. Epub 2011 Oct 27.

6.

HPV in exhaled breath condensate of lung cancer patients.

Carpagnano GE, Koutelou A, Natalicchio MI, Martinelli D, Ruggieri C, Di Taranto A, Antonetti R, Carpagnano F, Foschino-Barbaro MP.

Br J Cancer. 2011 Oct 11;105(8):1183-90. doi: 10.1038/bjc.2011.354. Epub 2011 Sep 27.

7.

Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.

Kusanagi Y, Kojima A, Mikami Y, Kiyokawa T, Sudo T, Yamaguchi S, Nishimura R.

Am J Pathol. 2010 Nov;177(5):2169-75. doi: 10.2353/ajpath.2010.100323. Epub 2010 Sep 9.

8.

Current status of cervical cancer and HPV infection in Korea.

Kim YT.

J Gynecol Oncol. 2009 Mar;20(1):1-7. doi: 10.3802/jgo.2009.20.1.1. Epub 2009 Mar 31.

9.

Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples.

Schenk T, Brandstetter T, Zur Hausen A, Alt-Mörbe J, Huzly D, Rühe J.

J Clin Microbiol. 2009 May;47(5):1428-35. doi: 10.1128/JCM.02080-08. Epub 2009 Mar 11.

10.

Human Papillomavirus type distribution in invasive cervical cancer in Uganda.

Odida M, de Sanjosé S, Quint W, Bosch XF, Klaustermeier J, Weiderpass E.

BMC Infect Dis. 2008 Jun 24;8:85. doi: 10.1186/1471-2334-8-85.

11.

Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.

Madsen BE, Ramos EM, Boulard M, Duda K, Overgaard J, Nordsmark M, Wiuf C, Hansen LL.

PLoS One. 2008 Jun 25;3(6):e2492. doi: 10.1371/journal.pone.0002492.

12.

Prognostic value of histopathology and trends in cervical cancer: a SEER population study.

Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos AT.

BMC Cancer. 2007 Aug 23;7:164.

Items per page

Supplemental Content

Write to the Help Desk